IFP Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Hold
0
3689
2025
Q1
Hold
0
3994
2024
Q4
Hold
0
4160
2023
Q2
Sell
-68
Closed -$1.35K 3481
2023
Q1
$1.35K Sell
68
-18
-21% -$569 ﹤0.01% 3019
2022
Q4
$3K Sell
86
-476
-85% -$13.6K ﹤0.01% 4000
2022
Q3
$18K Buy
562
+503
+853% +$17.7K ﹤0.01% 3180
2022
Q2
$2K Hold
59
﹤0.01% 4112
2022
Q1
$2K Buy
59
+56
+1,867% +$1.47K ﹤0.01% 4110
2021
Q4
$1K Buy
+3
New +$86 ﹤0.01% 2990
2019
Q1
Sell
-9
Closed 2665
2018
Q4
$0 Sell
9
-200
-96% -$4.63K ﹤0.01% 3626
2018
Q3
$6K Buy
209
+91
+77% +$2.17K ﹤0.01% 3122
2018
Q2
$2K Sell
118
-48
-29% -$909 ﹤0.01% 3575
2018
Q1
$2K Hold
166
﹤0.01% 3492
2017
Q4
$2K Buy
166
+157
+1,744% +$2.21K ﹤0.01% 3543
2017
Q3
$0 Hold
9
﹤0.01% 4103
2017
Q2
$0 Buy
+9
New +$216 ﹤0.01% 4114

Other funds holding EVH

IFP Advisors's EVH Position: Q2 2025 in Review

IFP Advisors held its Evolent Health (EVH) position steady in Q2 2025 at 0 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #3689.

IFP Advisors first reported a position in EVH in Q2 2017 and has held it in 13 quarters since. The position peaked at $18K in Q3 2022. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • IFP Advisors held 0 shares of Evolent Health worth $3.04K as of Q2 2025.
  • IFP Advisors left its Evolent Health share count unchanged in Q2 2025.
  • Evolent Health made up ﹤0.01% of IFP Advisors's portfolio in Q2 2025, its #3689 holding.
  • IFP Advisors first reported a position in Evolent Health in Q2 2017 and has held it in 13 quarters since.
  • IFP Advisors's Evolent Health position peaked at $18K in Q3 2022.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.